1SIUJ.ORG SIUJ • Volume 4, Number 1 • January 2023 Volume 4, Number 1 | January 2023 ISSN 2563-6499 10.48083/AGLR3780 Editorial Office info@siuj.org Tel: 514-875-5665 ext. 26 siuj.org Managing Editor Jane Fairbanks jane.fairbanks@siu-urology.org The SIUJ is published 6 times a year by the Société Internationale d'Urologie (SIU). It is the official peer-reviewed publication of the SIU but retains editorial independence. The SIUJ is circulated to urologists, urology residents, family medicine specialists, family medicine residents, general practitioners, nurses, medical libraries, and hospital and university departments of urology worldwide, for a total circulation of over 10,000. This publication was developed under the direction of the SIUJ Editorial Board. The SIUJ is published under an exclusive licence. The SIUJ is owned and published by the Société Internationale d’Urologie (SIU). Marketing Lillian Petrusa lillian.petrusa@siu-urology.org Advertising Mikaela Tierney advertising@siuj.org Neither the SIU nor the SIUJ endorses any service or the contents of any product referred to in any advertisement in the SIUJ. The SIU and the SIUJ assume no responsibility or liability for damages arising from any error or omission, or from the use of any information or advice contained in the SIUJ. All editorial matter in SIUJ represents the opinions of the authors and not necessarily those of the SIU or the SIUJ. All Canadian prescription drug advertisements have been cleared by the Pharmaceutical Advertising Advisory Board. Editorial Board Editor-in-Chief Peter C. Black, MD, Canada Deputy Editor Philippe E. Spiess, MD, United States Associate Editors Lysanne Campeau, MD, Canada Sandro Esteves, MD, Brazil Sanjay Sinha, MCh, India Henry Woo, MBBS, Australia Social Media Editor Jeremy Y. C. Teoh, MBBS, Hong Kong SAR Statistical Editor Alice Dragomir, PhD, Canada Innovators Editor Amanda Chung, MBBS, Australia Regional Editors North America Kathleen Kobashi, MD United States Middle East Yasser Osman, MBBCh Egypt South America Gonzalo Vitagliano, MD Argentina East Asia Tianxin Lin, MD China Eastern Europe Roman Sosnowski, MD Poland South Asia Gagan Prakash India Western Europe Tamsin Greenwell, MD United Kingdom Southeast Asia Edmund Chiong, MBBS Singapore Africa Evelyn Moshokoa, MBChB South Africa A NEW TREATMENT OPTION FOR PATIENTS WITH UROTHELIAL CARCINOMA (UC) PrOPDIVO® is indicated as a monotherapy for the adjuvant treatment of adult patients with UC who are at high risk of recurrence after undergoing radical resection of UC.1 Please consult the OPDIVO Product Monograph at https://www.bms.com/assets/bms/ca/documents/productmonograph/OPDIVO_EN_PM.pdf for contraindications, warnings, precautions, adverse reactions, drug interactions, dosing, and conditions of clinical use. The Product Monograph is also available by calling us at: 1-866-463-6267. Reference: 1. OPDIVO Product Monograph. Bristol-Myers Squibb Canada Co. OPDIVO and the OPDIVO logo are registered trademarks of Bristol-Myers Squibb Company used under license by Bristol-Myers Squibb Canada Co. 1506-CA-2200026E OPDIVO is indicated for the adjuvant treatment of adult patients with urothelial carcinoma (UC) who are at high risk of recurrence after undergoing radical resection of UC. OPDIVO has been issued marketing authorization with conditions, pending the results of trials to verify its clinical benefit. Patients should be advised of the nature of the authorization. For further information for OPDIVO please refer to Health Canada’s Notice of Compliance with conditions – drug products website. (https://w w w.canada.ca/en/health-canada/ser vices/drugs-health-products/drug-products/ notice-compliance/conditions.html) N E W I N D I C AT I O N http://SIUJ.org mailto:info%40siuj.org?subject=SIUJ http://siuj.org mailto:jane.fairbanks%40siu-urology.org?subject=SIUJ mailto:lillian.petrusa%40siu-urology.org%20?subject=SIUJ mailto:advertising%40siuj.org?subject=SIUJ SIUJ Cross-Out 2 SIUJ • Volume 4, Number 1 • January 2023 SIUJ.ORG Editorial Board Ahmed Adam, MBBCh South Africa Wayne Lam, MBBS Hong Kong SAR Fahad Alyami, MBBS Saudi Arabia Sang Dong Lee, MD Korea Mohsen Azli, MD Algeria Medina Ndoye, MD Senegal Erdem Canda, MD Türkiye Andrea Necchi, MD Italy Yao-Chi Chuang, MD Taiwan Dedan Opondo, MBChB Kenya Archil Chkhotua, MD Georgia Karima Oualla, MD Morocco Renu Eapen, MBBS Australia Lourdes Guerrios Rivera, MD Puerto Rico Agus Rizal Ardy Hariandy Hamid, MD Indonesia Mohammed Shahait, MD Jordan Thomas Herrmann, MD Switzerland Khurram Siddiqui, MBBS Oman Christopher Ho Chee Kong, MD Malaysia Yaya Sow, MD Senegal Theocharis Karaolides, MD Cyprus Chuan-Liang Xu, MD China Abdol - Mohammad Kajbafzadeh, MD Iran The Société Internationale d’Urologie (SIU). The Society’s mission is to enable urologists in all nations, through international cooperation in education and research, to apply the highest standards of urological care to their patients. The SIU is a major international platform for sustainable urological education and collaborative philanthropic activities aimed at improving urological care with more than 10 000 members from over 130 countries. SIU Central Office 1155 Robert-Bourassa Blvd., Suite 1012 Montreal, Quebec, Canada H3B 3A7 Tel: +1 514 875-5665 Fax: +1 514 875-0205 communications@siu-urology.org Executive Director Susie Petrusa susie.petrusa@siu-urology.org Graphic Design SAM Design info@studiosamdesign.com Web Design/ Technical Support AIKI Informatique info@aikitech.ca Volume 4, Number 1 | January 2023 Neither the SIU nor the SIUJ endorses any service or the contents of any product referred to in any advertisement in the SIUJ. The SIU and the SIUJ assume no responsibility or liability for damages arising from any error or omission, or from the use of any information or advice contained in the SIUJ. All editorial matter in SIUJ represents the opinions of the authors and not necessarily those of the SIU or the SIUJ. All Canadian prescription drug advertisements have been cleared by the Pharmaceutical Advertising Advisory Board. http://SIUJ.org mailto:communications%40siu-urology.org?subject=SIUJ mailto:susie.petrusa%40siu-urology.org?subject=SIUJ mailto:susie.petrusa%40siu-urology.org?subject=SIUJ mailto:info%40studiosamdesign.com%20?subject=SIUJ mailto:info%40studiosamdesign.com%20?subject=SIUJ mailto:info%40aikitech.ca?subject=SIUJ 3SIUJ.ORG SIUJ • Volume 4, Number 1 • January 2023 Table of Contents Editorial Standing on the Shoulders of Giants 5 Peter C. Black Urology Around The World SIU Training Scholarship: an Unforgettable Experience at the Muljibhai Patel Urological Hospital, Nadiad-Gujarat, India 8 Emmanuel Ugbede Oyibo Research Implementing HoLEP in an Academic Department With Multiple Surgeons in Training: Mentoring Is the Key for Success 11 Clément Klein, Thibault Marquette, Grégoire Capon, Eric Alezra, Peggy Blanc, Vincent Estrade, Jean-Christophe Bernhard, Franck Bladou, Grégoire Robert Disparities in Access to Virtual Care for Urinary Tract Infections During the COVID-19 Era 20 Molly E. DeWitt-Foy, Jacob A. Albersheim, Shawn T. Grove, Lina Hamid, Sally Berryman, Sean P. Elliott The LARCG Latin American Renal Cancer Group: Achievements in Support, Teaching, Research, Collaboration, and Advocacy 27 Stenio de Cássio Zequi, Francisco Rodriguez-Covarrubias, Ignacio Pablo Tobia, Alberto Jurado, Anamaria Autran Gomez, Luiz Meza-Montoya, Walter Henriques da Costa, Alejandro Nolazco, Thiago Camelo Mourao, Diego Abreu Oncologic Outcomes of a Novel Mapping Biopsy Technique Before Surgical Excision in the Management of Extramammary Paget Disease 34 Kyle M. Rose, Rosalie Zurlo, Roger Li, Gerard Mosiello, Philippe E. Spiess Review Salvage Versus Adjuvant Radiation Therapy Following Radical Prostatectomy in Localised Prostate Cancer: A War Without a Winner 40 Lara Rodriguez-Sanchez, Petr Macek, Camille Lanz, Qusay Mandoorah, Nuno Dias, Gianmarco Colandrea, Fernando P. Secin, Amandeep M. Arora, Rafael Sanchez-Salas, Xavier Cathelineau Urogenital Malignancy and Cannabis Use: A Narrative Review 51 Alice Thomson, Aoife McVey, Brennan Timm, Damien Bolton http://SIUJ.org 4 SIUJ • Volume 4, Number 1 • January 2023 SIUJ.ORG Table of Contents, Cont'd Giants in Urology Rudolf Hohenfellner, Chairman, Department of Urology, Johannes Gutenberg University, Mainz, Germany, 1967 to 1996 67 Jan Fichtner, Margit Fisch Clinical Picture Chronic Pelvic Organ Prolapse and Bladder Calculi in an Adolescent 69 Reyhane Ebrahimi, Alireza Soltani Khaboushan, Abdol-Mohammad Kajbafzadeh Incarcerated Internal Hernia Posterior to the Iliac Vessels After Uncomplicated Radical Cystectomy 71 Sydney Sparanese, Cyrus Chehroudi, Peter C. Black http://SIUJ.org This is an open access article under the terms of a license that permits non-commercial use, provided the original work is properly cited. © 2023 The Authors. Société Internationale d'Urologie Journal, published by the Société Internationale d'Urologie, Canada. SIUJ.ORG SIUJ • Volume 4, Number 1 • January 2023 5 EDITORIAL Standing on the Shoulders of Giants Peter C. Black, Editor-in-Chief Soc Int Urol J.2023;4(1):5 DOI: 10.48083/DMJD6674 Isaac Newton famously wrote in 1676: “If I have seen a little further it is by standing on the shoulders of Giants.” In this issue of the SIU Journal we introduce a new feature article that we will include regularly going forward: Giants in Urology. In medicine and surgery, we have a certain reverence for the pioneers who established the practices we incorporate into daily practice—but at the same time we have a short collective memory of those who have gone before us. Icons in the field who drift into retirement are quickly forgotten by the next generation of urologists emerging from training. For this reason, we wanted to feature some of these giants. We are certainly not the first urologic journal to do so, but, aligned with the mission of the SIUJ, we will do this from a global perspective, showcasing giants from around the world, including those whose impact was perhaps appreciated only regionally. Our first giant is Rudolf (“Rudy”) Hohenfellner, the long-time chairman of the Department of Urology at the Johannes Gutenberg University in Mainz, Germany. Reading this contribution from Jan Fichtner and Margaret Fisch reveals that this giant was himself influenced by giants that preceded him—and Hohenfellner has without question spawned multiple giants himself (the authors included). The legacy of passing on skills, techniques, and wisdom to one’s own trainees and junior faculty is without doubt a key feature of any giant in the field. Hohenfellner is like a godfather figure in German urology, as many chairs across the country started their careers under his tutelage. His surgical innovation has influenced many urologists around the world, benefitted not only all the patients he cared for but also all those cared for by his former trainees. I am myself one of the many trainees influenced by Rudy Hohenfellner. I had no idea who he was at the time, but he was the inspiration for me to pursue a career in urology. My first urologic experiences were his weekly lectures in the middle years of medical school. He regularly brought patients to his lectures and interviewed them with his thick Viennese accent to allow the students to learn from the individual medical histories and experiences of the patients. Urinary diversion was a regular feature in his lectures (Mainz is after all where he developed the Mainz pouch), and this was part of the inspiration for me to do an elective in urology. About 25 years later, I still do a lot of urinary diversion (although not the Mainz variety). As I finish a continent cutaneous reservoir or an orthotopic neobladder, I often wonder how we get away with these extensive reconstructive surgeries. At least we have decades of positive experiences on which to build, but imagine the early pioneers of urinary diversion like Hohenfellner who were developing the techniques that we have all since adopted. Perhaps more importantly, Hohenfellner instilled in his trainees many other lessons that were critical to the budding surgeon: discipline, technical excellence, scientific rigor, innovation, and devotion to the patient. I like to say that I might not do what I do today if I had not encountered Rudy Hohenfellner in the late 1990s in Mainz. I am reminded of a conversation I had with a very prominent Canadian urologist a few years ago on a subway in Washington DC. He was lamenting that the meeting to which we were both traveling used to attract many of the major “icons” (his term) in the field, but that he had noticed a gradual decline in this pattern over the years. What he did not recognize is that he had become an icon himself, and the urologists that he viewed as icons were mostly retired. There are many giants, and giants will come and go. Every urologist will have a different perspective on who is a giant in their region of the world and in their area of subspecialty practice. The impact of any given giant may be quite varied, including especially clinical research, translational research, biomarker and drug development, surgical innovation, modification of standard clinical practice, or exemplary leadership. Some giants will have contributed specifically to the success of urological organizations like the SIU, or to different urologic journals. We therefore invite contributions from urologists around the world. Share with us the inspiration your mentor has imparted to others. We would like to capture in the pages of the SIU Journal some of the main achievements of these giants, the quintessence of their personalities, and their legacy to our field. Who are the giants are in your urologic sphere? Upon whose shoulders do you stand? http://SIUJ.org mailto:editorinchief%40siuj.org?subject=SIUJ SAVE THE DATE In conjunction with Featuring the 5th B2B Uro–Oncology: GU Cancers Triad Meeting